Human rotavirus and vaccine composition comprising same

a technology of human rotavirus and vaccine composition, which is applied in the field of human rotavirus, can solve the problems of not easy to develop a new vaccine, and the cancellation of rotashield®

Active Publication Date: 2011-06-14
CHUNG ANG UNIV IND ACADEMIC COOP FOUND
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is not an easy task to develop a new vaccine which effectively works on all the identified infection serotypes (Glass R I et al., J Infect Dis 192 Suppl 1:S160-166, 2005).
However, FDA's approval of Rotashield® was canceled due to 15 cases of intussusception (Murphy T V et al., N Engl J Med 344:564-572, 2001).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human rotavirus and vaccine composition comprising same
  • Human rotavirus and vaccine composition comprising same
  • Human rotavirus and vaccine composition comprising same

Examples

Experimental program
Comparison scheme
Effect test

example 1

Isolation of Human Rotaviruses

Identification of P Genotype of Rotaviruses Isolated from Stool Specimens

[0046]Stool specimens obtained from 452 children infected by rotavirus and hospitalized in Chung-Ang University Yongsan Hospital in Seoul, South Korea were subjected to seminested multiplex PCR (Gouvea et al., J Clin. Microbiol. 28:276-282, 1990; 32:1338-1340, 1994) to identify P genotype.

[0047]The result of the seminested multiplex PCR analysis for VP4 gene showed that P genotype of the rotavirus was P[6] as shown in FIG. 1, while those for VP7 gene were two viruses without identifying G serotype thereof as shown in FIG. 2.

Identification of G Serotype of the Two Rotaviruses by Sequencing G7 Gene

[0048]VP7 gene was amplified by RT-PCR and subjected to gene sequencing to identify G serotype of the two viruses untyped in , as follows. Further, VP4 gene and NSP4 gene were also subjected to RT-PCR and gene sequencing.

[0049]First, the stool specimens obtained in were treated with TRI ...

example 2

Isolation of G12 Human Rotaviruses

[0054]The two rotaviruses, which were determined to have G12 serotype and P[6] genotype in Example 1, were isolated and purified according to the method of Nakagomi et al. (Nakagomi et al., J. Arch. Virol. 127:365-371, 1992). Specifically, the stool specimens were suspended in 5×PBS and filtered through a 0.22 μm filter. Then, the obtained suspensions were infected to MA104 cells (Prof. Linda J Saif, Ohio State University, USA) supplemented with 0.5% pancreatin and cultured in a 5% CO2 incubator until cytopathogenic effect appeared. The proliferated viruses were sub-cultured 2-3 times and subjected to RT-PCR.

[0055]The rotaviruses obtained as above were named as CAU 195 / G12 and CAU 214 / G12, and deposited in a depositary authority as Deposit Accession Nos: KCTC 10988BP and KCTC 10989BP.

[0056]FIG. 5 shows the cytopathogenic effect of the subject rotavirus CAU 195 / G12.

example 3

Study for Genetic Interrelation Between G12 Human Rotaviruses

Study for Genetic Interrelation Between VP7 gene of G12 Human Rotaviruses

[0057]To identify a subclass of CAU 195 / G12 and CAU 214 / G12, VP7 gene sequences thereof as confirmed in were multialigned with those of other G12 rotaviruses, e.g., L26 (Philippine), CP727 and CP1030 (Japan); Se585 (USA); T152 (Thailand); HC91 (Brazil); and RU172 (India), and the result of the multi-alignment was arranged in a similarity matrix using Clustal W (1.7) lo software (Thompson et al., Nucleic Acids Res 22: 4673-4680, 1994). Then, a phylogenetic tree was made based on the similarity matrix using neighbor-joining method (Saitou and Nei, Mol Biol Evo 4: 406-425, 1987).

[0058]As presented in FIG. 6, the nucleotide sequences of V7 genes of CAU 195 / G12 and CAU 214 / G12 showed >90% identity with those of other G12 rotaviruses; 99.5% with each other; 98.6% and 99.2% with Se585 (AJ31174); and 89.5% and 90.3% with L26 (M58290). As also illustrated in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
pHaaaaaaaaaa
pHaaaaaaaaaa
Login to view more

Abstract

Provided are G12 human rotaviruses having VP7 gene of SEQ ID NO: 1 or 2 and VP4 gene of SEQ ID NO: 3 or 4; antibodies specific for said rotaviruses; and a vaccine composition containing the same. The antibodies and the vaccine composition are effective for diagnosing rotavirus infection and for treatment of diseases caused by rotavirus.

Description

[0001]This is a national stage application under 35 U.S.C. §371 of PCT / KR2007 / 004751 filed on Sep. 28, 2007, which claims priority from Korean patent application 10-2006-0094867 filed on Sep. 28, 2006, all of which are incorporated herein by reference.FIELD OF THE INVENTION[0002]The present invention relates to a human rotavirus having VP7 gene represented by SEQ ID NO: 1 or 2 and VP4 gene represented by SEQ ID NO: 3 or 4.BACKGROUND OF THE INVENTION[0003]Rotavirus is a major cause of diarrhea in infants and young children throughout the world (World Health Organization: WHO WER 74:33-38, 1999). CDC (Center for Disease Control and Prevention) has reported that every year 440,000 infants and young children under 5 years of age die due to rotavirus infection. Under this circumstance, WHO has declared that the development of an anti-rotavirus vaccine is a project of the highest priority (Glass R I et al., Science 265:1389-1391, 1994). It has been reported that the situation in Korea is ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(United States)
IPC IPC(8): A61K39/15
CPCA61K39/12C07K16/10C12N7/00A61K2039/5252C12N2720/12321C12N2720/12334C12N15/11C07K16/08A61K39/15
Inventor KIM, WONYONGLIM, INSEOKPHAN, LE VANNAM, SUN-WOOYOON, JUNG-HOON
Owner CHUNG ANG UNIV IND ACADEMIC COOP FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap